Retatrutide 10 mg

RT-2026-008Lot RT10-100726-V17Analyzed October 11, 2026

Timeline

Ordered

October 7, 2026

Received

October 10, 2026

Analyzed

October 11, 2026

Sample

Name

Retatrutide 10 mg

Expected

Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

IN research

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

5.54mg

Label claim: 10 mg

Purity, how clean it is

>99%

by HPLC-UV peak area

Chromatogram

HPLC-UV

18.60 min, Retatrutide, >99%

Analyst Comments

White lyophilized powder, blue-cap vial, received sealed. Identity confirmed by co-injection with a retatrutide reference (single co-eluting peak).

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: October 11, 2026

Verification Code

RT-YHLT-9VBC

Verify at purilab.org/verify/RT-YHLT-9VBC

Scan to Verify

RT-YHLT-9VBC

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1